CPD Events

Genomic testing in lung cancer: The search for oncogenic drivers

20 Nov 2024

About the event

This educational webinar welcomes an expert faculty to discuss the current genomic testing pathways used in the UK to characterise oncogenic drivers in lung cancer and the factors to consider when carrying out these tests and interpreting the results. The faculty will also delve into real-world data; highlighting the importance of identifying oncogenic drivers with correct and timely testing to optimise treatment pathways.

CPD Provider

Merck Serono LTD

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Merck Serono LTD

Merck Serono LTD

Merck is a global science and technology company with a passion for forward-thinking discoveries. We want to develop products and solutions for a better life. That's why we take a closer look at things, ask questions and think ahead. More than 52,000 employees in 66 countries work together with us on innovative solutions and the newest technologies in healthcare, life science and performance materials. From improving electronic devices with smarter materials to generating ultra pure water, testing the quality of food and drugs, and treating cancer, Merck always promotes opportunities to break new ground.

Similar CPD Events

Healthcare & Medical
This Week

Recent advancements in colorectal cancer (CRC): Va...

Merck Serono LTD

This educational webinar welcomes an expert faculty to discuss the recent advancements in CRC with a...
12 Nov 2024